Care & practical questions A guidebook chapter
The questions people arrive with
Start with the question on your mind. Follow its chapter when you want the details.
Semax answers: September 30, 2026. Care rules: September 26, 2026.
Open an answer
Is Semax an approved US medicine?
As of September 30, 2026, the Food and Drug Administration (FDA) has not approved any US Semax product.
Russia’s registration answers a different country’s question.
Read the approval mapIs it proven to help focus?
Small human brain-scan studies have not established better focus or memory in daily life.
Read the focus chapterCan a prescription settle the pharmacy question?
No: under the rules checked in September 2026, a pharmacy cannot legally make Semax from its raw ingredient for a named patient.
503A is the law section for making medicine for a named patient, under conditions checked September 26, 2026.
This is this guide’s reading of the ingredient rules. A prescription alone does not answer them. Ask the doctor and pharmacist which rule permits their proposal.
Read the compounding chapterDo we know its unwanted effects?
The FDA found too little human information to describe Semax side effects reliably.
Read the cautionsHow do I find someone to ask?
Start with an assessment of your concern, in person or through licensed telehealth, meaning care by video, phone or messages. Ask who would treat you, their professional role, full name and licence details.
Read where to startWhat is the approved US price?
There is no US maker’s list price or government price for an approved Semax product as of September 30, 2026.
Read the cost questionsBrief source notes
At the end of this chapter
Keep this in mind.
For a care visit, ask what the proposed treatment is meant to change, what evidence supports it and which other options fit.